Tag: Migraines

Phase 3 data show efficacy and safety profile similar to intravenous administration

Decline in age-adjusted suicide rate from 2018 to 2020 followed by increases in 2021 and 2022

New indications include active psoriatic arthritis, nonradiographic axial spondyloarthritis with objective signs of inflammation, and ankylosing spondylitis

Findings seen for attention-deficit/hyperactivity disorder or depressive disorder

However, authors note this is likely underestimated and underdiagnosed

Additionally, family medicine-only staffed hospitals have stronger nursing-rated safety culture

For AML and MDS, lower utilization seen for non-Hispanic Black patients compared with other groups

No increased rates of positive M-CHAT-R screening seen for offspring

Standardized incidence ratios elevated for all nonkeratinocyte skin cancers, melanoma

Adeno-associated virus gene-therapy vector for hemophilia B superior for reducing annualized bleeding rate

Anti-CD20-treated primary progressive multiple sclerosis patients have higher risk for serious infection

Semaglutide added to standard treatments yields improvement in quality of life, reduction in flares

Cumulative incidence of first ischemic stroke was 2.1 percent by age 20 years, 13.5 percent by age 60 years

Better outcomes also seen for dyspnea compared with controls

Active suicidal ideation higher for cisgender males than females